Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Localized Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00295802
What this trial is testing

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP TMS S.A. 141
Testing effectiveness (Phase 2)Study completedNCT01250717
What this trial is testing

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 28
Not applicableLooking for participantsNCT04549688
What this trial is testing

Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
The Hospital of Vestfold 250
Large-scale testing (Phase 3)Study completedNCT00288080
What this trial is testing

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 612
Not applicableStudy completedNCT06372704
What this trial is testing

Is the HIFEM Procedure an Effective Treatment for Men With Post-prostatectomy Incontinence?

Who this might be right for
Prostate CancerIncontinencePelvic Floor Muscle Weakness
Kirsehir Ahi Evran Universitesi 27
Large-scale testing (Phase 3)UnknownNCT01398657
What this trial is testing

Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 182
Large-scale testing (Phase 3)UnknownNCT02016040
What this trial is testing

Focal Therapy Using HIFU for Localised Prostate Cancer

Who this might be right for
Prostate Cancer
Jewish General Hospital 25
Not applicableUnknownNCT03253978
What this trial is testing

SPORT High-Risk Trial Evaluating SABR in Prostate Cancer

Who this might be right for
Prostate Cancer
Belfast Health and Social Care Trust 40
Not applicableLooking for participantsNCT07560748
What this trial is testing

Prospective Prostate Cancer Infrastructure

Who this might be right for
High Risk Localized Prostate CancerSynchronous Metastatic Hormone-Sensitive Prostate Cancer
Radboud University Medical Center 700
Testing effectiveness (Phase 2)Ended earlyNCT00672009
What this trial is testing

Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Who this might be right for
Prostatic DiseasesGenital Neoplasms, MaleUrogenital Neoplasms+5 more
Cedars-Sinai Medical Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT07393867
What this trial is testing

Androgen-responsive POSLUMA-guided Intra-prostatic Boost

Who this might be right for
Intermediate Risk Prostate CancerHigh Risk Prostate CancerProstate Cancer
Martin T. King, MD, PhD 23
Testing effectiveness (Phase 2)Looking for participantsNCT06461793
What this trial is testing

Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)

Who this might be right for
High Risk Prostate Carcinoma
Samsung Medical Center 33
Large-scale testing (Phase 3)Active Not RecruitingNCT03531099
What this trial is testing

Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 108
Testing effectiveness (Phase 2)Looking for participantsNCT06582446
What this trial is testing

Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Not applicableStudy completedNCT03675529
What this trial is testing

The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.

Who this might be right for
Prostate Cancer
Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)Looking for participantsNCT06402357
What this trial is testing

High Intensity Focused Ultrasound in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Florida 25
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Testing effectiveness (Phase 2)Study completedNCT02789878
What this trial is testing

Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Instituto do Cancer do Estado de São Paulo 64
Not applicableWithdrawnNCT00877617
What this trial is testing

Quality of Life in Men With High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00466752
What this trial is testing

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage II Prostate CancerStage III Prostate Cancer
University of Washington 5
Next Page